CPBTD
ITCI

Central Pacific Bank - Trust Division’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Central Pacific Bank - Trust Division’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,645
Closed -$250K – 964
2024
Q2 		$250K Buy
3,645
+295
+9% +$20.5K 0.03% 491
2024
Q1 		$229K Buy
+3,350
New +$230K 0.03% 518

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Central Pacific Bank - Trust Division's ITCI Position: Q3 2024 in Review

Central Pacific Bank - Trust Division sold out of Intra-Cellular Therapies Inc. (ITCI) in Q3 2024, closing a stake of 3,645 shares — an estimated $250K sold.

Central Pacific Bank - Trust Division first reported a position in ITCI in Q1 2024 and held it in 2 quarters. The position peaked at $250K in Q2 2024. 355 funds tracked by Wall St. Rank hold ITCI as of Q3 2024.

  • Central Pacific Bank - Trust Division reported no remaining Intra-Cellular Therapies Inc. position as of Q3 2024 after selling out during the quarter.
  • Central Pacific Bank - Trust Division sold 3,645 Intra-Cellular Therapies Inc. shares in Q3 2024, an estimated $250K.
  • Central Pacific Bank - Trust Division first reported a position in Intra-Cellular Therapies Inc. in Q1 2024 and held it in 2 quarters.
  • Central Pacific Bank - Trust Division's Intra-Cellular Therapies Inc. position peaked at $250K in Q2 2024.
  • 355 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q3 2024.

Based on Central Pacific Bank - Trust Division's 13F filing for Q3 2024, filed 2 Oct 2024.